ARCHIVES

In Brief: Schmidt Sells OMB On Training Grants, But Weinberger Is The One To Convince

This article is from The Cancer Letter archive.

Vol. 01 No. 01 | December 21, 1973

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Follow-up Finds Finasteride Reduces Prostate Cancer Risk Without Affecting Lifespan

August 30, 2013

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

March 31, 2000

Waxman To Speak At AACI Meeting

January 12, 1979